Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Kane

Showing results (21-30 of 1,715) with videos related to

Pageof 172
Sort By:
Health Policy (Amsterdam, Netherlands)|August 5, 1997
Pharmaceutical cost containment and innovation in the United StatesN M Kane
The Journal of Clinical Psychiatry|May 1, 1994
Risperidone: new horizons for the schizophrenic patient. 9th World Congress of Psychiatry of the World Psychiatric Association, Rio de Janeiro, June 1993J M Kane
The Journal of Biological Chemistry|July 14, 1995
Disassembly and reassembly of the yeast vacuolar H(+)-ATPase in vivoP M Kane
Health Affairs (Project Hope)|March 1, 1997
Some guidelines for managing charitable assets from conversionsN M Kane
L'Encephale|December 1, 1996
[Clozapine in the treatment of schizophrenia]J M Kane
The Journal of Clinical Psychiatry|January 1, 1996
Treatment-resistant schizophrenic patientsJ M Kane
The British Journal of Psychiatry. Supplement|December 1, 1996
Factors which can make patients difficult to treatJ M Kane
The American Journal of Psychiatry|July 1, 1977
Improvement or relief from side effectsJ M Kane
Anesthesiology Clinics|April 14, 2009
Traditional fee-for-service Medicare payment systems and fragmented patient care: the backdrop for non-operating room procedures and anesthesia servicesNancy M Kane
Psychiatric Medicine|January 1, 1990
Psychopharmacologic treatment issuesJ M Kane
Pageof 172

Showing results (21-30 of 1,715) with videos related to

Sort By:
Pageof 172
Health Policy (Amsterdam, Netherlands)|August 5, 1997
Pharmaceutical cost containment and innovation in the United StatesN M Kane
The Journal of Clinical Psychiatry|May 1, 1994
Risperidone: new horizons for the schizophrenic patient. 9th World Congress of Psychiatry of the World Psychiatric Association, Rio de Janeiro, June 1993J M Kane
The Journal of Biological Chemistry|July 14, 1995
Disassembly and reassembly of the yeast vacuolar H(+)-ATPase in vivoP M Kane
Health Affairs (Project Hope)|March 1, 1997
Some guidelines for managing charitable assets from conversionsN M Kane
L'Encephale|December 1, 1996
[Clozapine in the treatment of schizophrenia]J M Kane
The Journal of Clinical Psychiatry|January 1, 1996
Treatment-resistant schizophrenic patientsJ M Kane
The British Journal of Psychiatry. Supplement|December 1, 1996
Factors which can make patients difficult to treatJ M Kane
The American Journal of Psychiatry|July 1, 1977
Improvement or relief from side effectsJ M Kane
Anesthesiology Clinics|April 14, 2009
Traditional fee-for-service Medicare payment systems and fragmented patient care: the backdrop for non-operating room procedures and anesthesia servicesNancy M Kane
Psychiatric Medicine|January 1, 1990
Psychopharmacologic treatment issuesJ M Kane
Pageof 172